# Filing Detail

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001062993-22-001182
Filing Date
2022-01-18
Accepted
2022-01-18 16:45:19
Documents
63
Period of Report
2021-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 20-F/A | form20fa.htm iXBRL | 20-F/A | 1188605
7 | GRAPHIC | form20faxz004.jpg | GRAPHIC | 14594
| Complete submission text file | 0001062993-22-001182.txt |  | 6350702

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | drug-20210930.xsd | EX-101.SCH | 97360
3 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | drug-20210930_cal.xml | EX-101.CAL | 25227
4 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | drug-20210930_def.xml | EX-101.DEF | 211441
5 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | drug-20210930_lab.xml | EX-101.LAB | 770595
6 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | drug-20210930_pre.xml | EX-101.PRE | 317363
57 | EXTRACTED XBRL INSTANCE DOCUMENT | form20fa_htm.xml | XML | 1029548

Mailing Address 19 VESTRY STREET NEW YORK NY 10013
Business Address 19 VESTRY STREET NEW YORK NY 10013 6474072515
BRIGHT MINDS BIOSCIENCES INC. (Filer) CIK: 0001827401 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 20-F/A | Act: 34 | File No.: 001-40997 | Film No.: 22535694
SIC: 2834 Pharmaceutical Preparations